Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

SLGL vs SKIN vs PRGO vs ELF

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SLGL
Sol-Gel Technologies Ltd.

Biotechnology

HealthcareNASDAQ • IL
Market Cap$197M
5Y Perf.-21.3%
SKIN
The Beauty Health Company

Household & Personal Products

Consumer DefensiveNASDAQ • US
Market Cap$75M
5Y Perf.-94.3%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.62B
5Y Perf.-75.7%
ELF
e.l.f. Beauty, Inc.

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$3.39B
5Y Perf.+179.9%

SLGL vs SKIN vs PRGO vs ELF — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SLGL logoSLGL
SKIN logoSKIN
PRGO logoPRGO
ELF logoELF
IndustryBiotechnologyHousehold & Personal ProductsDrug Manufacturers - Specialty & GenericHousehold & Personal Products
Market Cap$197M$75M$1.62B$3.39B
Revenue (TTM)$7M$296M$4.18B$1.52B
Net Income (TTM)$-15M$-6M$-1.82B$104M
Gross Margin-153.5%64.9%34.2%70.3%
Operating Margin-256.2%-3.6%-4.1%11.1%
Forward P/E5.5x19.6x
Total Debt$991K$379M$3.97B$313M
Cash & Equiv.$11M$233M$532M$149M

SLGL vs SKIN vs PRGO vs ELFLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SLGL
SKIN
PRGO
ELF
StockNov 20May 26Return
Sol-Gel Technologie… (SLGL)10078.7-21.3%
The Beauty Health C… (SKIN)1005.7-94.3%
Perrigo Company plc (PRGO)10024.3-75.7%
e.l.f. Beauty, Inc. (ELF)100279.9+179.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: SLGL vs SKIN vs PRGO vs ELF

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SLGL leads in 3 of 7 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Perrigo Company plc is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. ELF also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
SLGL
Sol-Gel Technologies Ltd.
The Growth Play

SLGL carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.

  • Rev growth 68.0%, EPS growth -478.9%, 3Y rev CAGR 70.9%
  • Lower volatility, beta 0.09, Low D/E 4.3%, current ratio 4.37x
  • Beta 0.09, current ratio 4.37x
  • 68.0% revenue growth vs SKIN's -10.0%
Best for: growth exposure and sleep-well-at-night
SKIN
The Beauty Health Company
The Quality Angle

SKIN lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: consumer defensive exposure
PRGO
Perrigo Company plc
The Income Pick

PRGO is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 10 yrs, beta 1.21, yield 9.8%
  • Lower P/E (5.5x vs 19.6x)
  • 9.8% yield; 10-year raise streak; the other 3 pay no meaningful dividend
Best for: income & stability
ELF
e.l.f. Beauty, Inc.
The Long-Run Compounder

ELF is the clearest fit if your priority is long-term compounding.

  • 129.7% 10Y total return vs SLGL's -48.0%
  • 6.8% margin vs SLGL's -227.4%
  • 4.5% ROA vs SLGL's -33.7%, ROIC 13.5% vs -48.6%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthSLGL logoSLGL68.0% revenue growth vs SKIN's -10.0%
ValuePRGO logoPRGOLower P/E (5.5x vs 19.6x)
Quality / MarginsELF logoELF6.8% margin vs SLGL's -227.4%
Stability / SafetySLGL logoSLGLBeta 0.09 vs ELF's 2.27, lower leverage
DividendsPRGO logoPRGO9.8% yield; 10-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)SLGL logoSLGL+8.2% vs SKIN's -53.2%
Efficiency (ROA)ELF logoELF4.5% ROA vs SLGL's -33.7%, ROIC 13.5% vs -48.6%

SLGL vs SKIN vs PRGO vs ELF — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SLGLSol-Gel Technologies Ltd.
FY 2025
License
95.9%$19M
Royalty
3.6%$707,000
Service, Other
0.4%$82,000
SKINThe Beauty Health Company
FY 2025
Consumables
70.7%$213M
Delivery Systems
29.3%$88M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B
ELFe.l.f. Beauty, Inc.

Segment breakdown not available.

SLGL vs SKIN vs PRGO vs ELF — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLSLGLLAGGINGSKIN

Income & Cash Flow (Last 12 Months)

ELF leads this category, winning 4 of 6 comparable metrics.

PRGO is the larger business by revenue, generating $4.2B annually — 637.0x SLGL's $7M. ELF is the more profitable business, keeping 6.8% of every revenue dollar as net income compared to SLGL's -2.3%. On growth, SLGL holds the edge at +8.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSLGL logoSLGLSol-Gel Technolog…SKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…ELF logoELFe.l.f. Beauty, In…
RevenueTrailing 12 months$7M$296M$4.2B$1.5B
EBITDAEarnings before interest/tax-$16M$9M$58M$235M
Net IncomeAfter-tax profit-$15M-$6M-$1.8B$104M
Free Cash FlowCash after capex$0$29M$108M$215M
Gross MarginGross profit ÷ Revenue-153.5%+64.9%+34.2%+70.3%
Operating MarginEBIT ÷ Revenue-2.6%-3.6%-4.1%+11.1%
Net MarginNet income ÷ Revenue-2.3%-2.0%-43.5%+6.8%
FCF MarginFCF ÷ Revenue+1.4%+9.7%+2.6%+14.1%
Rev. Growth (YoY)Latest quarter vs prior year+8.1%-6.7%-7.2%+37.8%
EPS Growth (YoY)Latest quarter vs prior year+132.2%+38.0%-56.4%+116.7%
ELF leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 3 of 6 comparable metrics.

On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than SKIN's 48.6x.

MetricSLGL logoSLGLSol-Gel Technolog…SKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…ELF logoELFe.l.f. Beauty, In…
Market CapShares × price$197M$75M$1.6B$3.4B
Enterprise ValueMkt cap + debt − cash$187M$221M$5.1B$3.6B
Trailing P/EPrice ÷ TTM EPS-32.21x-3.63x-1.14x31.70x
Forward P/EPrice ÷ next-FY EPS est.5.53x19.60x
PEG RatioP/E ÷ EPS growth rate0.78x
EV / EBITDAEnterprise value multiple48.65x7.43x17.59x
Price / SalesMarket cap ÷ Revenue10.18x0.25x0.38x2.58x
Price / BookPrice ÷ Book value/share8.65x1.29x0.55x4.67x
Price / FCFMarket cap ÷ FCF717.92x2.02x11.17x29.41x
PRGO leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

ELF leads this category, winning 6 of 9 comparable metrics.

ELF delivers a 8.9% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-51 for PRGO. SLGL carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to SKIN's 6.20x. On the Piotroski fundamental quality scale (0–9), SLGL scores 7/9 vs PRGO's 4/9, reflecting strong financial health.

MetricSLGL logoSLGLSol-Gel Technolog…SKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…ELF logoELFe.l.f. Beauty, In…
ROE (TTM)Return on equity-40.0%-9.4%-50.7%+8.9%
ROA (TTM)Return on assets-33.7%-1.2%-19.8%+4.5%
ROICReturn on invested capital-48.6%-6.8%+3.7%+13.5%
ROCEReturn on capital employed-28.0%-4.5%+4.3%+16.6%
Piotroski ScoreFundamental quality 0–97747
Debt / EquityFinancial leverage0.04x6.20x1.35x0.41x
Net DebtTotal debt minus cash-$10M$146M$3.4B$164M
Cash & Equiv.Liquid assets$11M$233M$532M$149M
Total DebtShort + long-term debt$991,000$379M$4.0B$313M
Interest CoverageEBIT ÷ Interest expense0.79x-7.20x6.48x
ELF leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

SLGL leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ELF five years ago would be worth $20,957 today (with dividends reinvested), compared to $471 for SKIN. Over the past 12 months, SLGL leads with a +816.7% total return vs SKIN's -53.2%. The 3-year compound annual growth rate (CAGR) favors SLGL at 25.3% vs SKIN's -62.5% — a key indicator of consistent wealth creation.

MetricSLGL logoSLGLSol-Gel Technolog…SKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…ELF logoELFe.l.f. Beauty, In…
YTD ReturnYear-to-date+68.1%-58.6%-13.6%-21.8%
1-Year ReturnPast 12 months+816.7%-53.2%-52.0%-10.4%
3-Year ReturnCumulative with dividends+96.8%-94.7%-58.1%-32.4%
5-Year ReturnCumulative with dividends-27.1%-95.3%-60.3%+109.6%
10-Year ReturnCumulative with dividends-48.0%-94.6%-77.7%+129.7%
CAGR (3Y)Annualised 3-year return+25.3%-62.5%-25.2%-12.2%
SLGL leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

SLGL leads this category, winning 2 of 2 comparable metrics.

SLGL is the less volatile stock with a 0.09 beta — it tends to amplify market swings less than ELF's 2.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SLGL currently trades 72.3% from its 52-week high vs SKIN's 21.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSLGL logoSLGLSol-Gel Technolog…SKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…ELF logoELFe.l.f. Beauty, In…
Beta (5Y)Sensitivity to S&P 5000.09x1.71x1.21x2.27x
52-Week HighHighest price in past year$97.97$2.69$28.44$150.99
52-Week LowLowest price in past year$6.80$0.57$9.23$58.05
% of 52W HighCurrent price vs 52-week peak+72.3%+21.6%+41.2%+40.3%
RSI (14)Momentum oscillator 0–10043.949.553.143.1
Avg Volume (50D)Average daily shares traded42K844K3.3M2.3M
SLGL leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 1 of 1 comparable metric.

Analyst consensus: SLGL as "Buy", SKIN as "Hold", PRGO as "Hold", ELF as "Buy". Consensus price targets imply 209.1% upside for PRGO (target: $36) vs -29.4% for SLGL (target: $50). PRGO is the only dividend payer here at 9.82% yield — a key consideration for income-focused portfolios.

MetricSLGL logoSLGLSol-Gel Technolog…SKIN logoSKINThe Beauty Health…PRGO logoPRGOPerrigo Company p…ELF logoELFe.l.f. Beauty, In…
Analyst RatingConsensus buy/hold/sellBuyHoldHoldBuy
Price TargetConsensus 12-month target$50.00$1.30$36.20$95.17
# AnalystsCovering analysts6133627
Dividend YieldAnnual dividend ÷ price+9.8%
Dividend StreakConsecutive years of raises101
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%+2.0%
PRGO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ELF leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallSol-Gel Technologies Ltd. (SLGL)Leads 2 of 6 categories
Loading custom metrics...

SLGL vs SKIN vs PRGO vs ELF: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SLGL or SKIN or PRGO or ELF a better buy right now?

For growth investors, Sol-Gel Technologies Ltd.

(SLGL) is the stronger pick with 68. 0% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). e. l. f. Beauty, Inc. (ELF) offers the better valuation at 31. 7x trailing P/E (19. 6x forward), making it the more compelling value choice. Analysts rate Sol-Gel Technologies Ltd. (SLGL) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SLGL or SKIN or PRGO or ELF?

On forward P/E, Perrigo Company plc is actually cheaper at 5.

5x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — SLGL or SKIN or PRGO or ELF?

Over the past 5 years, e.

l. f. Beauty, Inc. (ELF) delivered a total return of +109. 6%, compared to -95. 3% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: ELF returned +129. 7% versus SKIN's -94. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SLGL or SKIN or PRGO or ELF?

By beta (market sensitivity over 5 years), Sol-Gel Technologies Ltd.

(SLGL) is the lower-risk stock at 0. 09β versus e. l. f. Beauty, Inc. 's 2. 27β — meaning ELF is approximately 2517% more volatile than SLGL relative to the S&P 500. On balance sheet safety, Sol-Gel Technologies Ltd. (SLGL) carries a lower debt/equity ratio of 4% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — SLGL or SKIN or PRGO or ELF?

By revenue growth (latest reported year), Sol-Gel Technologies Ltd.

(SLGL) is pulling ahead at 68. 0% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, SLGL leads at 70. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SLGL or SKIN or PRGO or ELF?

e.

l. f. Beauty, Inc. (ELF) is the more profitable company, earning 8. 5% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ELF leads at 12. 0% versus -39. 2% for SLGL. At the gross margin level — before operating expenses — SLGL leads at 99. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SLGL or SKIN or PRGO or ELF more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

5x forward P/E versus 19. 6x for e. l. f. Beauty, Inc. — 14. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 209. 1% to $36. 20.

08

Which pays a better dividend — SLGL or SKIN or PRGO or ELF?

In this comparison, PRGO (9.

8% yield) pays a dividend. SLGL, SKIN, ELF do not pay a meaningful dividend and should not be held primarily for income.

09

Is SLGL or SKIN or PRGO or ELF better for a retirement portfolio?

For long-horizon retirement investors, Sol-Gel Technologies Ltd.

(SLGL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 09)). e. l. f. Beauty, Inc. (ELF) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SLGL: -48. 0%, ELF: +129. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SLGL and SKIN and PRGO and ELF?

These companies operate in different sectors (SLGL (Healthcare) and SKIN (Consumer Defensive) and PRGO (Healthcare) and ELF (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SLGL is a small-cap high-growth stock; SKIN is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock; ELF is a small-cap high-growth stock. PRGO pays a dividend while SLGL, SKIN, ELF do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SLGL

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 407%
Run This Screen
Stocks Like

SKIN

Quality Business

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Gross Margin > 38%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen
Stocks Like

ELF

High-Growth Disruptor

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 18%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SLGL and SKIN and PRGO and ELF on the metrics below

Revenue Growth>
%
(SLGL: 814.6% · SKIN: -6.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.